Niki BioSolutions NIKI
NASDAQ NIKI
$4.81 -0.09 (-1.83%)
As of: Oct 1, 2026 · 2:11 PM EDT

Niki BioSolutions (NIKI) Long-Term Deferred Tax (2024 - 2025)

Updated

Niki BioSolutions (NIKI) posted Long-Term Deferred Tax of $384,624 for Q4 2025, down 33.7% from $579,833 a year earlier.

Analysis

Niki BioSolutions (NIKI) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends

  • In prior years, Niki BioSolutions' Long-Term Deferred Tax was $579,833 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Niki BioSolutions 2.67 Mn 2.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2025 384,624.00
May 31, 2024 579,833.00
API Access

Niki BioSolutions Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=NIKI&period=max&api_key=YOUR_API_KEY